• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

    25.36 +1.21 (+5.01%)
    Streaming Delayed Price Updated: 11:41 AM EDT, Mar 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Regencell Bioscience Holdings Limited - Ordinary Shares

    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Regencell, Beyond Meat, Alvotech, and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network
    LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with the team from Regencell Bioscience Holdings... 
    From Stock News Now
    Via AccessWire
    News headline image
    Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    News headline image
    Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
    From Regencell Bioscience Holdings Limited
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.